Cilfa Opposition, Estradiol, (Ar107022 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, mesalazine, (AR108231A1)
Countries: Argentina Date: 2018
-
CILFA opposition, fenibrutinib, (AR107751A1)
Countries: Argentina Date: 2018
-
CILFA opposition, bempedoic acid, (AR114396A1)
Countries: Argentina Date: 2020
-
CILFA opposition, pirfenidone , (AR112474A1)
Countries: Argentina Date: 2020
-
CILFA opposition, botulinum toxin A, (AR112121A1)
Countries: Argentina Date: 2019
-
CILFA opposition, dapagliflozin-empagliflozin-insulin, (AR112015A1)
Countries: Argentina Date: 2019
-
CILFA opposition, cariprazine, (AR112137A1)
Countries: Argentina Date: 2019
-
CILFA opposition, buprenorphine, (AR110468A1)
Countries: Argentina Date: 2019
-
CILFA opposition, oprozomib, (AR110374A1)
Countries: Argentina Date: 2019
-
CILFA opposition, ibrutinib, (AR107391)
Countries: Argentina Date: 2019